Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sexual and Marital Dysfunction in Women With Gynecologic Cancer.
Guntupalli SR, Sheeder J, Ioffe Y, Tergas A, Wright JD, Davidson SA, Behbakht K, Flink DM. Guntupalli SR, et al. Among authors: davidson sa. Int J Gynecol Cancer. 2017 Mar;27(3):603-607. doi: 10.1097/IGC.0000000000000906. Int J Gynecol Cancer. 2017. PMID: 28129243
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study.
Alvarez RD, Sill MW, Davidson SA, Muller CY, Bender DP, DeBernardo RL, Behbakht K, Huh WK. Alvarez RD, et al. Among authors: davidson sa. Gynecol Oncol. 2014 Jun;133(3):433-8. doi: 10.1016/j.ygyno.2014.03.571. Epub 2014 Apr 4. Gynecol Oncol. 2014. PMID: 24708919 Free PMC article. Clinical Trial.
Biphasic tumors of the female genital tract.
Lyle P, Evans R, Jarboe E, Fong D, Behbakht K, Davidson S, Singh M. Lyle P, et al. Oncology (Williston Park). 2005 Aug;19(9):1178, 1183, 1188, 1190, 1195-6 passim. Oncology (Williston Park). 2005. PMID: 16255134 Free article. No abstract available.
A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy.
Spannuth WA, Leath CA 3rd, Huh WK, Barnes MN 3rd, Davidson SA, Kilgore LC, Partridge EE, Austin JM 2nd, Alvarez RD. Spannuth WA, et al. Among authors: davidson sa. Gynecol Oncol. 2007 Mar;104(3):591-5. doi: 10.1016/j.ygyno.2006.09.008. Epub 2006 Oct 12. Gynecol Oncol. 2007. PMID: 17045635 Clinical Trial.
96 results